VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,383 | -56.1% | 361 | -9.8% | 0.00% | – |
| Q2 2023 | $7,710 | +175.0% | 400 | +100.0% | 0.00% | – |
| Q1 2023 | $2,804 | +70000.0% | 200 | -10.3% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 223 | +11.5% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 200 | -50.0% | 0.00% | – |
| Q1 2022 | $6,000 | -25.0% | 400 | +100.0% | 0.00% | – |
| Q4 2021 | $8,000 | -11.1% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -66.7% | 200 | -66.2% | 0.00% | -100.0% |
| Q2 2021 | $27,000 | -18.2% | 591 | -11.3% | 0.00% | 0.0% |
| Q1 2021 | $33,000 | +120.0% | 666 | +9.9% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | -6.2% | 606 | +28.7% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | +128.6% | 471 | +135.5% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |